SoftMedx Healthcare Cash Flow Statement

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	326.32	12.51	-19.23	-26.28
Depreciation & Amortization	0.59	1.19	2.04	1.19
Loss (Gain) From Sale of Assets	-	4.73	-	-7.95
Asset Writedown & Restructuring Costs	-	-	0.35	-
Loss (Gain) From Sale of Investments	16.61	-19.08	0.73	2.74
Other Operating Activities	-333.23	8.9	11.22	10.76
Change in Accounts Receivable	-9.63	-10.03	0.63	1.38
Change in Inventory	-1.95	-0.86	-1.97	-
Change in Accounts Payable	7.59	2.76	-	-
Change in Other Net Operating Assets	-2.43	-4.61	3.39	11.54
Operating Cash Flow	3.88	-4.49	-2.84	-6.62
Capital Expenditures	-	-	-0.53	-0.52
Divestitures	-	-0.05	-	-0.73
Investment in Securities	-	-1.16	-	0.56
Other Investing Activities	0.19	0.36	-	-
Investing Cash Flow	0.19	-0.85	-0.53	-0.7
Long-Term Debt Issued	25.03	13.53	7.24	17.05
Total Debt Issued	25.03	13.53	7.24	17.05
Long-Term Debt Repaid	-28.35	-3.18	-4.55	-7.07
Net Debt Issued (Repaid)	-3.33	10.34	2.7	9.98
Issuance of Common Stock	-	-	0.2	-
Other Financing Activities	-0.04	-0.04	-0.1	-0.07
Financing Cash Flow	-3.36	10.31	2.8	9.91
Net Cash Flow	0.71	4.97	-0.58	2.6
Free Cash Flow	3.88	-4.49	-3.38	-7.14
Free Cash Flow Margin	7.10%	-8.75%	-10.00%	-420.36%
Free Cash Flow Per Share	0.01	-0.01	-0.01	-0.02
Cash Interest Paid	0.04	0.04	0.1	0.07
Cash Income Tax Paid	-0.08	1.33	0.26	-
Levered Free Cash Flow	-79.41	-18.55	-5.35	-23.06
Unlevered Free Cash Flow	-78.58	-10.46	4.36	-12.89
Change in Working Capital	-6.42	-12.74	2.05	12.92

Source: S&P Global Market Intelligence. Standard template. Financial Sources.